BiliaryTractCancer near Newton, NJ

Biography: After receiving her BS in Biology at the University of North Texas, Dr. Evelyn Taiwo obtained her MD at Temple University School of Medicine in Philadelphia. Following her residency at Boston University Medical Center, she completed a three-year fellowship in hematology and oncology at the University of Texas Southwestern Medical Center in Dallas. Prior to joining Weill Cornell Medicine, Dr. Taiwo served as Assistant Professor of Medicine at the State University of New York, Downstate Medical Center in Brooklyn from July 2011-2019, and as Attending Physician and Site Director for the Hematology-Oncology Fellowship Program at Kings County Hospital. While at Kings County Hospital, she served in a leadership role as Director of the Breast Cancer Clinic, overseeing the operations, research activities, clinical care delivery, and education. As a researcher, Dr. Taiwo has contributed to a number of studies on cancer presentation in urban and minority patient populations.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person nbsp;

Biography: Dr. Despina Siolas received her Bachelor of Science with summa cum laude honors from St. John's University. She attended medical school at Stony Brook University, where she was awarded the prestigious E-Trade Financial Scholarship from the Hellenic Medical Society of New York. In addition to her MD degree, Dr. Siolas is the recipient of a Doctor of Philosophy in Genetics from the State University of New York at Stony Brook for studies she conducted in the lab of Greg Hannon PhD, Howard Hughes Medical Institute Professor, at Cold Spring Harbor Laboratory. She completed her internal medicine residency training and hematology/oncology fellowship at NYU Langone Health. In addition to treating patients, Dr. Siolas conducts research on cancer genes that influence the immune microenvironment using preclinical models of pancreatic cancer and colon cancer. She has authored numerous publications and has received a prestigious Mentored Clinical Scientist Research Career Development Award (K08) from the National Institute of Health. She is a member of the American Society for Clinical Oncology, the American Association for Cancer Research, and American Medical Association, and Hellenic Medical Society.

Biography: Dr. Accordino graduated from The Pennsylvania State University with a bachelor of science in Pre-medicine with minors in Health Policy and Administration and Biology. She completed her medical degree at The Pennsylvania State University College of Medicine. While in medical school she was elected to Alpha Omega Alpha, the national medical honor society which recognizes high educational achievement. She completed her Internal Medicine residency at Weill Cornell Medical Center and her Medical Hematology/Oncology fellowship at Columbia University Medical Center, where she served as Chief Fellow. During that time, she was awarded a Conquer Cancer Foundation of the American Society of Clinical Oncology Young Investigator Award and Merit Award. She also served as a Postdoctoral Research Fellow in Cancer-Related Population Sciences supported by the National Cancer Institute for her work in quality improvement and health outcomes research. Upon fellowship graduation she became an Assistant Professor of Medicine within the Division of Hematology/Oncology at Columbia University. Since her faculty appointment she has received grant funding from multiple agencies including: The American Society of Clinical Oncology, The HOPE Foundation, The Breast Cancer Research Foundation, The American Cancer Society, and the National Institutes of Health/National Cancer Institute. Dr. Accordino is currently involved in patient care, clinical research, education, and quality improvement. Dr. Accordino's research aims to improve the quality and delivery of cancer care, and cancer survivorship. Dr. Accordino participates in clinical trials at the local, national, and international level. She also has experience leading multicenter cancer trials through the SWOG Cooperative Group. The overall goal of her research is to improve quality and outcomes within oncology.